Intervention

Tullio Palmerini , Carlo Savini , Marco Di Eusanio ,

Yan Topilsky ,

Alia Noorani , Vinayak Bapat ,

Tullio Palmerini , Adriano Caixeta , Gregg W Stone ,

Sameer Gafoor , Jennifer Franke , Stefan Bertog , et al

Michael Tittelbach , Tobias Diener ,

Georgios J Vlachojannis , Bimmer E Claessen , George D Dangas ,

Rajiv Rampat , David Hildick-Smith ,

Kamal Chitkara , Anthony H Gershlick ,

John Rawlins , Jehangir Din , Suneel Talwar , et al

Hellmuth Weich ,

About

Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Media

Nicolas M Van Mieghem, Joost Daemen, Roxana Mehran, et al

Watch time: 1h

Justin E Davies,

Javier Escaned,

Watch time: 47m 14s

Javier Escaned,

Watch time: 47m 14s

Roberto Diletti,

Watch time: 1h 2m 9s

Marcelo Guimaraes, ,

Watch time: 11m 9s

Hitoshi Matsuo, Allen Jeremias,

Watch time: 38m 56s

Andrew SP Sharp, Indranil Dasgupta, Felix Mahfoud, et al

Watch time: 1h 13m 4s

Dr Won-Keun Kim,

Watch time: 43m 44s

Robert Gerber, Andrew SP Sharp,

Watch time: 58m 14s

Manesh R Patel, Justin E Davies,

Watch time: 6m 25s

Keith AA Fox, Dominick J Angiolillo,

Watch time: 37m 37s

Articles

Patent Foramen Ovale Closure in 2019

Joel P Giblett

,

Omar Abdul-Samad

,

Leonard M Shapiro

,

Bushra S Rana

,

Patrick A Calvert

,

Citation:

Interventional Cardiology Review 2019;14(1):34–41

DOI:

https://doi.org/10.15420/icr.2018.33.2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 546
  • Downloads: Downloads 0
  • Citations: 24

Common and Uncommon CTO complications

Colm Hanratty

,

Simon J Walsh

,

Citation:

Interventional Cardiology Review 2018;13(3):121–5

DOI:

https://doi.org/10.15420/icr.2018.10.2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 526
  • Downloads: Downloads 0
  • Citations: 7

Why Did COAPT Win While MITRA-FR Failed? Defining the Appropriate Patient Population for MitraClip

Kimberly Atianzar

,

Ming Zhang

,

Zachary Newhart

,

Sameer Gafoor

,

Citation:

Interventional Cardiology Review 2019;14(1):45–7

DOI:

https://doi.org/10.15420/icr.2018.40.1
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 562
  • Downloads: Downloads 0
  • Citations: 18

FFRCT for Complex Coronary Artery Disease Treatment Planning: New Opportunities

Jonathon A Leipsic

,

Jonathan Weir-McCall

,

Philipp Blanke

,

Citation:

Interventional Cardiology Review 2018;13(3):126-8.

DOI:

https://doi.org/10.15420/icr.2018.14.3
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 340
  • Downloads: Downloads 0
  • Citations: 9